Literature DB >> 18925618

Hypophosphatasia: molecular testing of 19 prenatal cases and discussion about genetic counseling.

Brigitte Simon-Bouy1, Agnès Taillandier, Delphine Fauvert, Isabelle Brun-Heath, Jean-Louis Serre, Carmen G Armengod, Martin G Bialer, Michèle Mathieu, Jacques Cousin, David Chitayat, Jan Liebelt, Barbara Feldman, Marion Gérard-Blanluet, Stefani Körtge-Jung, Cath King, Hannele Laivuori, Martine Le Merrer, Sarju Mehta, Christina Jern, Saba Sharif, Fabienne Prieur, Gabriele Gillessen-Kaesbach, Andreas Zankl, Etienne Mornet.   

Abstract

OBJECTIVE: We studied hypophosphatasia (HP) mutations in 19 cases prenatally detected by ultrasonography without familial history of HP. We correlated the mutations with the reported ultrasound signs, and discussed genetic counseling with regard to the particular dominantly inherited prenatal benign form of HP.
METHOD: The coding sequence of the tissue nonspecific alkaline phosphatase (TNSALP) gene was analyzed by DNA sequencing, and 3D modeling was used to locate the mutated amino acids with regard to the functional domains of TNSALP.
RESULTS: Although reported ultrasound signs were heterogeneous, two mutated alleles were found in 18 of the 19 cases studied, indicating recessive transmission of the disease. Functional domains of TNSALP were affected by 74% of missense mutations. In all the cases, including one with only a heterozygous mutation, molecular, biological, and familial data do not corroborate the hypothesis of prenatal benign HP. The mutation c.1133A>T observed in the prenatal benign form of HP and common in USA was not found in this series.
CONCLUSION: The results point out the prenatally detectable allelic heterogeneity of HP. The nature of the detected mutations and the evidence of recessive inheritance do not support these cases being affected with prenatal benign HP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925618     DOI: 10.1002/pd.2088

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  6 in total

Review 1.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

2.  New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis.

Authors:  Sibylle Sabrautzki; Isabel Rubio-Aliaga; Wolfgang Hans; Helmut Fuchs; Birgit Rathkolb; Julia Calzada-Wack; Christian M Cohrs; Matthias Klaften; Hartwig Seedorf; Sebastian Eck; Ana Benet-Pagès; Jack Favor; Irene Esposito; Tim M Strom; Eckhard Wolf; Bettina Lorenz-Depiereux; Martin Hrabě de Angelis
Journal:  Mamm Genome       Date:  2012-04-21       Impact factor: 2.957

3.  Current concepts in odontohypophosphatasia form of hypophosphatasia and report of two cases.

Authors:  Zhu-Yu Wang; Kai Zhang; Guang-Sen Zheng; Wei Qiao; Yu-Xiong Su
Journal:  BMC Oral Health       Date:  2016-08-17       Impact factor: 2.757

4.  Clinical Practice Guidelines for Hypophosphatasia.

Authors:  Toshimi Michigami; Yasuhisa Ohata; Makoto Fujiwara; Hiroshi Mochizuki; Masanori Adachi; Taichi Kitaoka; Takuo Kubota; Hideaki Sawai; Noriyuki Namba; Kosei Hasegawa; Ikuma Fujiwara; Keiichi Ozono
Journal:  Clin Pediatr Endocrinol       Date:  2020-01-09

Review 5.  Differential diagnosis of perinatal hypophosphatasia: radiologic perspectives.

Authors:  Amaka C Offiah; Jerry Vockley; Craig F Munns; Jun Murotsuki
Journal:  Pediatr Radiol       Date:  2018-10-03

6.  Skeletal mineralization: mechanisms and diseases.

Authors:  Toshimi Michigami
Journal:  Ann Pediatr Endocrinol Metab       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.